EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphoma.
about
Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in miceThe histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type.JAK3-mediated phosphorylation of EZH2: a novel mechanism of non-canonical EZH2 activation and oncogenic functionElevated expression of a pharmacologic Polycomb signature predicts poor prognosis in gastric and breast cancer.Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer.Ezh2 phosphorylation state determines its capacity to maintain CD8+ T memory precursors for antitumor immunity.EZH2 Modulates the DNA Methylome and Controls T Cell Adhesion Through Junctional Adhesion Molecule A in Lupus Patients.Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL.Expression of enhancer of zeste homolog 2 (EZH2) protein in histiocytic and dendritic cell neoplasms with evidence for p-ERK1/2-related, but not MYC- or p-STAT3-related cell signaling.Regulation of the positive transcriptional effect of PLZF through a non-canonical EZH2 activity.Androgens Regulate Ovarian Gene Expression Through Modulation of Ezh2 Expression and Activity.Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential.[The biological complexity of Polycomb group proteins: the case of EZH2].Deoxyribonucleic Acid Methylation in Systemic Lupus Erythematosus: Implications for Future Clinical Practice.LEE011 and ruxolitinib: a synergistic drug combination for natural killer/T-cell lymphoma (NKTCL)
P2860
Q33707337-ADBE7572-BB6E-4746-96CA-13A098B76CD5Q38706007-43CE1C8A-BDB2-49B8-BB0A-8A0727C626C5Q41576148-7FC3DEC8-78B3-4C21-A614-8E1526590055Q42688119-B27C61AF-7A1B-4CE6-B8E9-4E385EB7C747Q46629789-76E7595B-8D95-40C0-A9DE-220418D01826Q47152771-C0846529-D207-4401-B809-35D8BF47D052Q47705643-0FE7B693-7103-4AA7-9F36-A9C12F607C88Q49959048-0992BBFA-0F2E-4A10-8AC9-3B658E774EE5Q50071606-BED092AD-9149-4049-BD5B-FFD82CF6A650Q50098940-414206C8-2AFE-47A8-B0B6-A0A63BCEAAD9Q50914466-FF72D75F-471A-4CF2-A910-202EF5FD470FQ52349529-1D281BE8-259F-4090-B641-94E19E37933DQ52607784-16401849-31B1-4C8D-8887-C9E2F3FFA2D3Q54986273-DDEAD658-BB16-4A67-A350-FC34737382A5Q58796912-E3D38357-BE2B-44E3-852D-B18231EB550D
P2860
EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
EZH2 phosphorylation by JAK3 m ...... atural killer/T-cell lymphoma.
@en
type
label
EZH2 phosphorylation by JAK3 m ...... atural killer/T-cell lymphoma.
@en
prefLabel
EZH2 phosphorylation by JAK3 m ...... atural killer/T-cell lymphoma.
@en
P2093
P50
P1433
P1476
EZH2 phosphorylation by JAK3 m ...... atural killer/T-cell lymphoma.
@en
P2093
Baohong Lin
Chonglei Bi
Henry Yang
Pei Tsung Lee
Tae-Hoon Chung
Wee-Joo Chng
Xue Ting Lee
P304
P356
10.1182/BLOOD-2016-01-690701
P407
P577
2016-06-13T00:00:00Z